16-03-2023, 16:04

Medigene to present first pre-clinical data for MDG1015

Martinsried/Munich, March 16, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early stage immuno-oncology
Globe Newswire16-03-2023, 16:04
9-03-2023, 22:25

2023 SXSW Conference Hosts Psychedelic Healthcare VC Fund

CHICAGO and NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) -- As therapeutic applications of psychedelics gain more
Globe Newswire9-03-2023, 22:25
8-03-2023, 01:02

LanzaTech (LNZA) Announces New Board Members to Accelerate

New directors bring diverse wealth of experience across sustainable development, corporate finance, and social impact
Globe Newswire8-03-2023, 01:02
28-02-2023, 07:27

Alvotech Announces Webcast of 2022 Full Year Financial

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar
Globe Newswire28-02-2023, 07:27
6-02-2023, 16:08

Alvotech enters into commercialization agreement with

Advanz Pharma will commercialize AVT23, a proposed biosimilar to Xolair® (omalizumab) in the European Economic Area,
Globe Newswire6-02-2023, 16:08
2-02-2023, 20:05

Surface Oncology to Participate in the 2023 Guggenheim

CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology
Globe Newswire2-02-2023, 20:05
2-02-2023, 02:42

Premiere Synthetic Biology Event on Track for Record

SynBioBeta Global Synthetic Biology Conference Registration Open SynBioBeta announces event dates, keynotes, sponsors,
Globe Newswire2-02-2023, 02:42
31-01-2023, 21:19

Envision Pharma Group Hires Leading Industry Executives

PHILADELPHIA, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Envision Pharma Group (Envision) today announced the appointment of
Globe Newswire31-01-2023, 21:19